609817-15-4Relevant academic research and scientific papers
Dimerization and isomerization reactions of α-lithiated terminal aziridines
Hodgson, David M.,Humphreys, Philip G.,Miles, Steven M.,Brierley, Christopher A. J.,Ward, John G.
, p. 10009 - 10021 (2008/03/28)
(Chemical Equation Presented) The scope of dimerization and isomerization reactions of α-lithiated terminal aziridines is detailed. Regio-and stereoselective deprotonation of simple terminal aziridines with lithium 2,2,6,6-tetramethylpiperidide (LTMP) or lithium dicyclohexylamide (LiNCy 2) generates trans-α-lithiated terminal aziridines. These latter species can then undergo dimerization or isomerization reactions depending on the nature of the N-protecting group. α-Lithiated terminal aziridines bearing N-alkoxycarbonyl (Boc) protection undergo N- to C-[1,2] migration to give N-H trans-aziridinylesters. In contrast, aziridines bearing N-organosulfonyl [tert-butylsulfonyl (Bus)] protection undergo rapid dimerization to give 2-ene-1,4-diamines or, if a pendant alkene is present, diastereoselective cyclopropanation to give 2-aminobicyclo[3.1.0]hexanes. All of these reactions were used as key steps in the preparation of synthetically and biologically important targets.
Synthesis and biological activity of piperazine-Based dual MMP-13 and TNF-α converting enzyme inhibitors
Letavic, Michael A.,Barberia, John T.,Carty, Thomas J.,Hardink, Joel R.,Liras, Jennifer,Lopresti-Morrow, Lori L.,Mitchell, Peter G.,Noe, Mark C.,Reeves, Lisa M.,Snow, Sheri L.,Stam, Ethan J.,Sweeney, Francis J.,Vaughn, Marcie L.,Yu, Chul H.
, p. 3243 - 3246 (2007/10/03)
A series of novel MMP-13 and TNF-α converting enzyme inhibitors based on piperazine 2-hydroxamic acid scaffolds are described. The TACE, MMP-1 and MMP-13 activity of these inhibitors as well as the effect of substitution of the piperazine nitrogen and the P-1′ benzyloxy tailpiece is discussed. Moderate in vivo activity is observed with several members of this group.
